Form 4: Apellis Pharmaceuticals VP Sells Shares to Cover Tax Withholding
SEC Form 4 Filing
James George Chopas, VP/Chief Accounting Officer of Apellis Pharmaceuticals, sold 184 shares of common stock on March 15, 2024, to cover tax obligations related to released Restricted Stock Units.
Summary
- On March 15, 2024, James George Chopas, VP/Chief Accounting Officer of Apellis Pharmaceuticals, sold 184 shares of common stock.
- The sale was executed at a price of $56.461 per share.
- The transaction was to cover tax withholding on Restricted Stock Units released on March 14, 2024.
- Following the transaction, Chopas directly owns 38,883 shares of Apellis Pharmaceuticals.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations when stock options or restricted stock units vest. The sale itself is unlikely to have a significant impact on the stock price, but it's part of the regular flow of insider trading activity that investors monitor.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Restricted Stock Units released |
| 03/15/2024 | Date of stock sale |
| 03/18/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.